What's new? Log in Free sign up

Transcript search / Precipio Inc / "R&D"

13 transcripts

Earnings call transcript

to unleash our talented R&D team to continue developing and bringing to market other products that have similar value and similar market opportunity

Earnings call transcript

or market it's the team that is able to take all those components and execute. We have a capable R&D team that's created product and market wants, at our

Earnings call transcript

companies from any other diagnostic company. We developed a unique three-pronged business model. So one side, we have an R&D team that can develop

Earnings call transcript

is to provide clinical results to our customers. And the second is to support our R&D team in continuing to identify, examine and develop technologies

Earnings call transcript

can tell you that through my ongoing interaction with our R&D team, there is nothing more rewarding than knowing that a technology that we've worked

Earnings call transcript

of the laboratories outside the U.S., which we've been in contact with will be more open to exploring bringing this valuable technology into their own lab. Our R&D team

Earnings call transcript

in selling and R&D initiatives. Within R&D in 2021, we were actively working on the development of a suite of HemeScreen panels and as we build

Earnings call transcript

qualified -- high quality service focused on diagnostic accuracy. But the laboratory way to provide services is also a playground of sorts for our R&D team

Earnings call transcript

an improved version of IV-cell. While this is still in R&D stages, initial results are exciting and we believe that we will come out of this period

Earnings call transcript

revenue dollar heals 55% to 60% margins. Moving onto our operating expenses. The company's operating expenses consists of sales, marketing, R&D, public

Earnings call transcript

has reviewed; from the R&D team, our sales organization and our diagnostic lab located in New Haven, Connecticut. Each group has done Yeoman's [ph

Earnings call transcript

-recurring expenses attributable to ICP moving from R&D lab environment to the production lab where demo kits are being prepared for evaluation

Earnings call transcript

setup ICP in their laboratory and assist in the onboarding of their technology. At the same time, in my discussions with one of our R&D team members

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.